Abstract:Objective To investigate the effects of simvastatin on vascular endothelial function and hypersensitivity C-reactive protein(hs-CRP) in patients with type 2 diabetes mellitus(T2DM).Methods A total of 32 T2DM patients and 25 control subjects received the treatment of 20 mg/d simvastatin for 12 months.Endothelial dependent flow-mediated vasodilation(FMD) was assessed at baseline,after 1 month and 12 months of simvastatin therapy.Serum lipid profiles,hs-CRP,fasting glucose(FPG),fasting insulin(FIns) and homeostasis model assessment-insulin resistance(HOMA-IR) were measured simultaneously.Results ①Simvastatin significantly improved serum lipid disorders in patients with T2DM.② Compared with baseline level,there was no change of FMD in pateints with T2DM after one month simvastatin treatment.Furthermore,no significant increase of FMD was found after 12-month simvastatin treatment [(5.65±0.65)% vs.(6.10±0.71)%,P﹥0.05].In contrast,simvastatin treatment caused a significant improvement of FMD in control subjects.③A significant reduction of hs-CRP level was observed in patients with T2DM after 12-month treatment.④ Simvastatin had no effect on FPG,FIns and HOMA-IR in both groups.Conclusions Despite of substantial lowering of lipid parameters and inflammatory marker after 12-month simvastatin therapy,no improvement of endothelium-dependent vasodilation is found in T2DM.

The Effects of Simvastatin Therapy on Endothelial Function and Inflammatory Factor in Type 2 Diabetes Mellitus Without Cardiovascular Disease